Financière de Tubize S.A. Stock

Equities

TUB

BE0003823409

Pharmaceuticals

Market Closed - Euronext Bruxelles 11:35:23 2024-04-19 am EDT 5-day change 1st Jan Change
91.9 EUR +0.11% Intraday chart for Financière de Tubize S.A. -1.71% +28.17%
Sales 2022 0.01 0.01 Sales 2023 - Capitalization 3.19B 3B
Net income 2022 85M 79.79M Net income 2023 88M 82.61M EV / Sales 2022 392,371,878,420 x
Net Debt 2022 46.73M 43.87M Net Debt 2023 78.63M 73.81M EV / Sales 2023 -
P/E ratio 2022
37 x
P/E ratio 2023
36.2 x
Employees 3
Yield 2022
1.21%
Yield 2023
1.35%
Free-Float 29.31%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.11%
1 week-0.11%
Current month+2.22%
1 month+5.39%
3 months+26.58%
6 months+31.29%
Current year+28.17%
More quotes
1 week
91.00
Extreme 91
93.40
1 month
88.30
Extreme 88.3
94.00
Current year
71.70
Extreme 71.7
94.00
1 year
60.80
Extreme 60.8
94.00
3 years
60.80
Extreme 60.8
100.80
5 years
49.80
Extreme 49.8
100.80
10 years
48.05
Extreme 48.045
100.80
More quotes
Members of the board TitleAgeSince
Director/Board Member - -
Director/Board Member 74 81-12-31
Director/Board Member 53 07-12-31
More insiders
Date Price Change Volume
24-04-19 91.9 +0.11% 6,545
24-04-18 91.8 -0.65% 12,329
24-04-17 92.4 +0.11% 8,226
24-04-16 92.3 -0.11% 10,435
24-04-15 92.4 -1.18% 20,119

Real-time Euronext Bruxelles, April 19, 2024 at 11:35 am EDT

More quotes
Financière de Tubize S.A. is a holding company that owns 36.24% of the listed biopharmacy group UCB.
Calendar
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
91.9 EUR
Average target price
118.2 EUR
Spread / Average Target
+28.67%
Consensus